Articles by Stevo Julius

1 2 3 4 5

Management of the hypertensive patient with elevated heart rate: Statement of the Second Consensus Conference endorsed by the European Society of Hypertension

Palatini, Paolo; Rosei, Enrico Agabiti; Casiglia, Edoardo; More

Journal of Hypertension. 34(5):813-821, May 2016.


Ruilope, Luis M; Zanchetti, Alberto; Julius, Stevo; More

Journal of Hypertension. 26(1):154, January 2008.

Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial

Ruilope, Luis M; Zanchetti, Alberto; Julius, Stevo; More

Journal of Hypertension. 25(7):1473-1479, July 2007.

Ambulatory blood pressure monitoring after 1 year on valsartan or amlodipine-based treatment: a VALUE substudy

Pedersen, Ole Lederballe; Mancia, Giuseppe; Pickering, Thomas; More

Journal of Hypertension. 25(3):707-712, March 2007.

Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an analysis of findings from the VALUE trial

Zanchetti, Alberto; Julius, Stevo; Kjeldsen, Sverre; More

Journal of Hypertension. 24(11):2163-2168, November 2006.

Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial

Kjeldsen, Sverre E; Julius, Stevo; Mancia, Giuseppe; More

Journal of Hypertension. 24(7):1405-1412, July 2006.

Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting

Palatini, Paolo; Benetos, Athanase; Grassi, Guido; More

Journal of Hypertension. 24(4):603-610, April 2006.

Long-term treatment with losartan versus atenolol improves insulin sensitivity in hypertension: ICARUS, a LIFE substudy

Olsen, Michael H; Fossum, Eigil; Høieggen, Aud; More

Journal of Hypertension. 23(4):891-898, April 2005.

Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy

Ibsen, Hans; Wachtell, Kristian; Olsen, Michael H; More

Journal of Hypertension. 22(9):1805-1811, September 2004.

Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers?

Zanchetti, Alberto; Hansson, Lennart; Clement, Denis; More

Journal of Hypertension. 21(4):797-804, April 2003.

Benefit and harm of low-dose aspirin in well-treated hypertensives at different baseline cardiovascular risk

Zanchetti, Alberto; Hansson, Lennart; Dahlöf, Björn; More

Journal of Hypertension. 20(11):2301-2307, November 2002.

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

Lindholm, Lars H.; Ibsen, Hans; Borch-Johnsen, Knut; More

Journal of Hypertension. 20(9):1879-1886, September 2002.

Relative influence of insulin resistance versus blood pressure on vascular changes in longstanding hypertension. ICARUS, a LIFE sub study

Olsen, Michael H.; Fossum, Eigil; Hjerkinn, Elsa; More

Journal of Hypertension. 18(1):75-81, 2000.

Hyperkinetic borderline hypertension in Tecumseh, Michigan

Julius, Stevo; Krause, Lisa; Schork, Nicholas J.; More

Journal of Hypertension. 9(1):77-84, January 1991.

1 2 3 4 5